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Follow the Leader: Minireview
NK Cell Receptors for Classical
and Nonclassical MHC Class I
and KIR3D molecules are heterogeneous. Isoforms with
long cytoplasmic tails (i.e., KIR2DL and KIR3DL) contain
ITIM that bind SHP-1 and inactivate NK cells. KIRs with
short cytoplasmic domains (KIR2DS and KIR3DS) lack
ITIM, but possess charged amino acids in their trans-
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membrane segments that permit association with DAP12,
a membrane receptor expressing an immunoreceptor
tyrosine-based activation motif (ITAM), that provides forNatural killer (NK) cells participate in the innate immune
NK cell activation (Lanier et al., 1998). While the HLAresponse against certain viruses, intracellular bacteria,
class I specificity of certain KIR isoforms remains un-parasites, and transformed cells (reviewed by Trinchieri,
known or controversial, there is consensus that the1989). Unlike B cells and T cells, NK cells do not express
KIR2DL1 and KIR2DL2 molecules recognize a poly-immunoglobulins or T cell antigen receptors, and until
morphism of HLA-C that maps to amino acids 77 andrecently there was little insight into how these cells dis-
80 in the HLA-C heavy chain (Figure 1). Amino acid 44criminate self fromnonself. The first clue about the work-
in the first Ig-domain of KIR2DL1 and KIR2DL2 dic-ings of NK cells came from the observation that NK cells
tates recognition of this HLA-C polymorphism. Similarly,preferentially kill cells lacking major histocompatibility
KIR3DL1 recognizes a polymorphism in the a1 domaincomplex (MHC) class I on the cell surface. Based on
of the HLA-B heavy chain in a region defining the Bw4this observation, KaÈ rre and colleagues (Ljunggren and
serological epitope (Figure 1). Both KIR2D and KIR3DKaÈ rre, 1990) proposed that NK cells recognize and elimi-
molecules bind to HLA class I trimers, composed ofnate cells that are ªmissing self.º As predicted, NK cells
a class I heavy chain, b2-microglobulin, and a boundhave been shown to express receptors for MHC class
peptide. The class I±bound peptide can influence KIRI that upon ligation inhibit NK cell-mediated cytotoxicity
recognition, but there is no obvious distinction betweenand cytokine secretion (reviewed by Lanier, 1997). While
ªselfº versus foreign peptides. The structure of a KIR2Dit is still uncertain what initiates the activation of NK cells
protein has been solved, and it is similar to the familyagainst virus-infected or transformed cells, the process
of hematopoietic growth factor receptors (Fan et al.,whereby expression of MHC class I on the antigen-
1997). Like the Ly49 receptors, different KIR moleculespresenting cell negatively regulates NK cell behavior
are displayed on overlapping subsets within the totalis providing new and unexpected insights about the
NK cell population and the repertoire of expressed re-immune system.
ceptors is heterogeneous in different individuals. KIRThree distinct types of membrane receptors ex-
genes have been identified in humans and other pri-pressed on NK cells bind MHC class I ligands and inhibit
mates, but not in rodents.killing of class I±bearing target cells (reviewed by Lanier,
Functional studies of human NK cells revealed that in1997). Mouse NK cells express MHC class I receptors
addition to KIR, another type of receptor is responsibleencoded by a small family of genes, designated Ly49A±
for recognition of MHC class I. This receptor, designatedLy49I, that are present on chromosome 6 in a region
CD94/NKG2, is a heterodimer, composed of a CD94called the ªNK gene complexº (reviewed by Yokoyama
glycoprotein that is disulfide-bondedto either an NKG2Aand Seaman, 1993). Human homologs of the Ly49 genes
subunit or an NKG2C subunit (reviewed by Lanier, 1997).have not been found. Ly49 receptors are type II glyco-
The CD94, NKG2A, and NKG2C genes are present onproteins of the C-type lectin superfamily expressed as
human chromosome 12 p12.3±p13.1 and the mousedisulfide-bonded homodimers on overlapping subsets
CD94 gene is located on the syntenic mouse chromo-within the total NK cell population of mice and rats. Ly49
some 6. CD94 lacks a cytoplasmic domain, but is re-receptors recognize a trimeric MHC class I complex
quired for transport and membrane expression of thecomposed of the H-2D or H-2K heavy chain, b2-micro-
NKG2A or NKG2C glycoproteins. Although similar inglobulin, and a bound peptide; however, the composi-
their extracellular regions, NKG2A possesses an ITIM intion of the bound peptide does not appear to greatly
the cytoplasmic domain, whereas the NKG2C moleculeinfluence the interaction. Most, but not all, of the Ly49
lacks an ITIM, but contains a basic amino acid in thereceptors contain an immunoreceptor tyrosine-based
transmembrane that may provide for association withinhibitory motif (ITIM) in their cytoplasmic domains.
other signaling-transducing proteins.Upon tyrosine phosphorylation, the ITIM recruits SH2-
Mapping the specificity of the KIR and Ly49 receptorscontaining tyrosine phosphatase-1 (SHP-1) or SHP-2
to the a1 domain of the HLA or H-2 class I heavy chainthat subsequently inhibits NK cell effector function (re-
was a relatively straightforward exercise. In contrast,viewed by Lanier, 1997).
attempts to define the specificity of CD94/NKG2 failedHuman NK cells express receptors for MHC class I
to provide satisfying answers. In these studies, anencoded by the Killer cell Inhibitory Receptor (KIR) gene
HLA-A, -B, and -C deficient EBV-transformed B lympho-family present on chromosome 19q13.4. The KIR mole-
blastoid cell line, 721.221, was transfected with cDNAcules are monomeric type I glycoproteins that contain
encoding different alleles of the HLA-A, -B, -C, andeither 2 or 3 Ig-like domains in their extracellular region,
-G genes. The NK-sensitive 721.221 cell line and thedesignated KIR2D and KIR3D, respectively (reviewed by
Lanier, 1997). The cytoplasmic domains of the KIR2D transfectants were assayed for their susceptibility to
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of a biological function for HLA-E, a nonclassical class
Ib molecule.
The peptides bound in the groove of the mouse class
Ib molecule Qa-1 are derived from the leader segments
of the classical H-2D and H-2L proteins (Aldrich et al.,
1994). New findings reveal that HLA-E, the human homo-
log of Qa-1, also predominantly binds leader peptides
originating from HLA-A, -B, -C, and -G proteins (Braud
et al., 1997, 1998b; Lee et al., 1998a). Both Qa-1 and
HLA-E demonstrate limited polymorphism, are broadly
expressed in tissues, and require a functional TAP het-
erodimer for the assembly of class I leader peptides in
the HLA-E or Qa-1 groove. Of note, neither Qa-1 nor
HLA-E possess leader segments that are permissive for
transport of these molecules to the cell surface, making
them dependent upon the by-products of other classical
class I polypeptides for their expression. While Qa-1
serves as a weak transplantation antigen and can be
recognized by alloantigen-specific CTL, until now there
has been no clues about the physiological role of a
class 1b molecule capable of binding leader segments
Figure 1. Inhibitory NK Cell Receptor for HLA Class I of classical MHC class I proteins. Using fluorochrome-
Diagrammatic representation of the HLA class I specificity of labeled tetrameric complexes composed of HLA-E heavy
KIR2DL1, KIR2DL2, KIR3DL1, and CD94/NKG2A. KIR molecules
chains and b2-microglobulin, loaded with a 9 amino acidcontain 2 or 3 Ig-like domains in the extracellular region and two
peptide derived from the leader sequence of HLA-B8,ITIM sequences in thecytoplasmic region. CD94 and NKG2Acontain
Braud and colleagues (Braud et al., 1998a) have shownC-type lectin domains in the extracellular region and NKG2A has two
ITIM sequences in the cytoplasmic region. KIR2DL1 and KIR2DL2 physical binding of these HLA-E molecules to the CD94/
recognize a polymorphic epitope at residues 77 and 80 in the a1 NKG2A and CD94/NKG2C receptors. HLA-E tetramers
domain of the HLA-C heavy chain, as indicated. KIR and CD94/ do not bind either CD94 or NKG2 chains alone, but
NKG2A receptors bind to the trimeric MHC class I molecule, com- only bind to the heterodimer. Despite the fact that
posed on an HLA-E heavy chain, a bound peptide, and b2-micro-
CD94 and NKG2 are members of the C-type lectin super-globulin. KIRsrecognize HLA-B and HLA-C possessing conventional
family, recombinant HLA-E proteins lacking carbohy-peptides in the binding groove, whereas the peptides present in
drate strongly bind to these receptors, indicating thatthe HLA-E binding groove are composed of hydrophobic leader
segments derived from HLA-A, -B, -C, or -G molecules. lectin interactions are not essential to the specificity.
The nonameric class I±derived peptides binding to
Qa-1 and HLA-E demonstrate similar structural charac-
killing by NK cell clones expressing CD94/NKG2A recep- teristics and have identical anchor residues at positions
tors, in the presence or absence of neutralizing anti- 2 (Met) and 9 (Leu). An analysis of the sequences of the
CD94 monoclonal antibodies. Results from these experi- leader peptides of different human HLA class I alleles
ments suggested that most, but not all, HLA-A, -B, -C, that are permissive or nonpermissive for binding HLA-E
and -G transfectants were protected from killing by NK provided an obvious resolution to why some, but not
cells using the CD94/NKG2A receptor. But there were all, class I transfectantsof the 721.221 cell line are recog-
no obvious structural similarities in the extracellular do- nized by NK cells expressing CD94/NKG2A receptors.
mains of the protective HLA-A, -B, -C, or -G alleles that While 721.221 cells do not expressHLA-A, -B, -C, and -G
mapped the CD94/NKG2A recognition site. This prob- genes, these cellsdo possess immature HLA-E polypep-
tides in the cytoplasm, but not on the cell surface. Whenlem has now been resolved by investigations in search
Figure 2. Membrane Expression of HLA-E
Requires Peptides Derived from the Leader
Segments of Certain HLA-A, -B, -C, or -G Pro-
teins
721.221 is a human EBV-transformed B lym-
phoblastoid cell line lacking expression of
HLA-A, -B, -C, or -G. HLA-E polypeptides are
synthesized by 721.221, but are retained
and degraded intracellularly. Transfection of
721.221 cells with HLA-A, -B, -C, or -G genes
expressing leader segments with permissive
peptide sequences allows TAP-dependent
assembly of mature HLA-E molecules and
presentation on the cell surface.
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721.221 cells are transfected with HLA class I genes nonclassical and classical class I molecules, permit-
ting NK cells expressing CD94/NKG2 to detect changespossessing a leader segment permissive for HLA-E
binding, mature HLA-E molecules are assembled and in HLA-E or Qa-1 and other NK cells expressing Ly49
(in rodents) or KIR (in primates) to monitor alterationspresented on the cell surface for interaction with CD94/
NKG2A receptors (Figure2). Results from several labora- in conventional H-2 or HLA class I molecules.
tories have verified that CD94/NKG2 is a specific recep-
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The capacity of HLA-E to preferentially bind leader
segments of class I molecules provides a clever biologi-
cal solution to explain how NK cells expressing essen-
tially nonpolymorphic receptors can monitor the expres-
sion of class I molecules that are constantly undergoing
genetic diversification. Essentially, HLA-E acts as the
sentinel to reflect the global status of class I on the cell,
detecting events that disrupt the synthesis or transport
of conventional class I molecules. The beauty and ele-
gance of the system is that it allows an invariant NK
cell receptor to interact with a highly conserved ligand
HLA-E, yet keep check on the highly polymorphic and
rapidly diversifying class I genes. However, has this
strategy gone unnoticed by pathogens? A potential
counterattack measure would be to disrupt normal class
Ia synthesis to avoid detection by T cells, yet produce
pathogen-derived proteins with leader segments per-
missive for HLA-E binding to evade NK cell surveillance.
While an attractive concept, perhaps this provides the
rationale for the existence of NK cell receptors for both
